Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Astragaloside II is a triterpene saponin that has been found in A. membranaceus and has diverse biological activities.1,2,3,4,5 It increases the phosphatase activity of CD45 in cell-free assays using 4-nitrophenyl phosphate (pNPP; Item No. 34081) or OMFP as substrates (EC50s = 9.23 and 5.37 µg/ml, respectively).1 Astragaloside II inhibits replication of dengue virus serotypes 1 and 3 in infected Vero cells (MIC = 1.56 µg/ml for both).2 It increases concanavalin A-induced proliferation of primary mouse splenocytes when used at a concentration of 30 nM.1 Astragaloside II (50 µM) inhibits autophagy and enhances apoptosis induced by the DNA-crosslinking agent cisplatin (Item No. 13119) in SGC-7901 gastric cancer cells.3 It prevents decreases in small intestine and colon length, as well as body weight, in a mouse model of TNBS-induced colitis when administered at a dose of 10 mg/kg.4 Astragaloside II (3.2 and 6.4 mg/kg) decreases the urinary albumin-to-creatinine ratio and improves histopathological scores in a rat model of diabetic nephropathy induced by streptozotocin (STZ; Item No. 13104).5
WARNING This product is not for human or veterinary use.
1. Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity. Acta Pharmacol. Sin. 34(4), 522-530 (2013).
2. Antiviral activity of astragaloside II, astragaloside III and astragaloside IV compounds against dengue virus: Computational docking and in vitro studies. Microb. Pathog. 152, 104563 (2021).
3. AstragalosideII inhibits autophagic flux and enhance chemosensitivity of cisplatin in human cancer cells. Biomed. Pharmacother. 81, 166-175 (2016).
4. Astragaloside II promotes intestinal epithelial repair by enhancing L-
5. Astragaloside II ameliorated podocyte injury and mitochondrial dysfunction in streptozotocin-